Journal of Natural Products · 1996 · 54 citations · 10 references
DerivativesRaocyclamides ABiochemistryCyanobacterium Oscillatoria RaoiMedicineHeterocyclicRaocyclamide BOrganic ChemistryAntibacterial AgentMicrobiologyHeterocycle ChemistryCyanobacteriaPharmacologyDerivative (Chemistry)Drug Discovery
Raocyclamides A and B, two novel oxazole- and thiazole-containing cyclic hexapeptides, were isolated from the cyanobacterium Oscillatoria raoi (TAU strain IL-76−1−2). The gross structures of raocyclamides A (1) and B (2) were elucidated by homonuclear and inverse-heteronuclear 2D-NMR techniques and HREIMS. The absolute stereochemistry of compounds 1 and 2 was determined by Marfey's HPLC Method. Raocyclamide A (1) was established as cyclo-thiazole-d-Ile-oxazole-l-Ala-d-oxazoline-d-Phe and raocyclamide B (2) as cyclo-thiazole-d-Ile-oxazole-l-Ala-d-Ser-d-Phe. Raocyclamide A (1) exhibits a moderate cytotoxicity against sea urchin embryos.
10
Pharmaceuticals from cultured algae
Robert E. Schwartz, C. F. Hirsch, David F. Sesin et al. · Journal of Industrial Microbiology & Biotechnology · 1990 · 310 citations · Full text
Trimurtulu Golakoti, Ikuko I. Ohtani, Gregory M. L. Patterson et al. · Journal of the American Chemical Society · 1994 · 301 citations
Pharmaceutical Science, Bioorganic Chemistry, Altmetric Attention Score +18